🇺🇸 FDA
Patent

US 10406233

Telodendrimers with enhanced drug delivery

granted A61KA61K47/32A61K47/595

Quick answer

US patent 10406233 (Telodendrimers with enhanced drug delivery) held by The Regents of the University of California expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K47/32, A61K47/595, A61K47/60, A61K47/645